News About: Pharm. Industry
Tai Guk Pharm acquires dermatological EU-GMP for first time in KoreaTai Guk Pharm(CEO Chang-gu Lee), the largest domestic pharmaceutical company specializing in dermatological products, announced acquisition of the pharmaceutical EU-GMP(Europe G...
|
Long-cherished wish will be addressed for distribution companies
The government has prepared a special measure for shortage-prevented pharmaceutical products that are necessary to treat patients not to encounter difficulties in supply.
It basically decided to prohibit selling prod...
Multinational pharmaceuticals keep 3 months to collect drug payments
Multinational pharmaceutical companies branched in the Korean market were observed to take about 3 months on average to collect payments from selling pharmaceutical products.
The length was a month faster than domest...
Domestic pharmaceuticals made KRW 94 from selling product of KRW 1,000 last year
Domestic pharmaceutical companies were observed to earn KRW 94 from selling a product worth of KRW 1,000 last year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audit reports turned in by ...
Pharmaceutical companies look glamorous outside, but polarization was intensified
It was analyzed pharmaceutical companies made glamorous profits, but the polarization of wealth among them was intensified last year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audit rep...
Celltrion, “Janssen’s Remsima patent infringement lawsuit is unreasonable”When it comes to the Janssen’s Remsima patent infringement lawsuit(request to accelerate screening), Celltrion argued the US7,598,083 is a patent related to a badge containing t...
|
High cost/sales rate leads to low profitability for multinational pharmaceuticals
Multinational pharmaceutical companies were observed to have low profitability due to high cost/sales rates.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audit reports of 32 multinational ...
Performance of each pharmaceutical company competing for joint promotion
A rare atmosphere was recently formed among domestic pharmaceutical companies which compete over introduction of blockbuster products.
In this process, a number of products were switched for companies to jointly prom...
Multinational pharmaceuticals earn KRW 25 out of products worth KRW 1,000
Multinational pharmaceutical companies were analyzed to make only KRW 25 out of selling a product worth of KRW 1,000 in the Korean market.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2015 audi...
Roche Korea appoints Matt Sause as new CEORoche Korea announced the appointment of Matt Sause as a new CEO.
CEO Matt Sause will take charge in every department of Roche Korea, a part of Roche Group.
After joining Roc...
|
